CDC Information for Health Care Professionals: https://www.cdc.gov/coronavirus/2019-nCoV/hcp/index.html
Monoclonal Antibody Treatments for COVID-19 (Bamlanivimab and Regeneron): The linked letter and referral form below are intended to provide updated information regarding the referral process and available Maryland infusion sites for the two FDA EUA-approved monoclonal antibody (mAb) treatments for COVID-19: bamlanivimab (Eli Lilly) and the antibody combination, casirivimab/imdevimab (Regeneron). Early data for these therapeutics suggest that they may reduce the risk of hospitalization for people at high risk who have tested positive for COVID-19 and have only mild to moderate symptoms.
Starting April 2022, calls will be held monthly on the first Thursday at noon. Some summary slides are available on off weeks.
The Centers for Disease Control and Prevention (CDC) and state public health authorities are investigating confirmed and probable cases of Mpox (in the orthopoxvirus genus) throughout multiple states. Click here to learn more. The Frederick County Health Department is monitoring the emerging public health issue and taking action for local public health preparedness. Healthcare providers should remain vigilant for the possibility of human Mpox virus infection and be ready to identify possible cases, isolate them, and test for the virus.
General information about signs, symptoms, and resources like fact sheets can be found here.
Local healthcare providers should immediately report any suspected cases of Mpox ore residents who have had exposure to a probable/confirmed Mpox case to the Frederick County Health Department:
Update from Frederick County Medical Officer: